Adding Amplitech Group (AMPG) $5.04 to Watch List.
LIVE QUOTE
Now locked...
Drones Take Flight to Disinfect Sports, Entertainment Venues.
DroneLife
A Pittsburgh-based drone company has received the FAA’s blessing to use drones to disinfect public venues.
Meet Draganfly (DFLYF) the Tesla of Drones.
A New Leader In The Drone Industry Emerges
US Government Bans Chinese Drones
Surprise...
Goldman Sachs Likes the Drone Industry, and So Do We.
GOLDMAN SACHS INSIGHTS: DRONES
SPECIAL REPORT
Adding Draganfly (DFLYF) $1.40 to Watch List.
Amnnounces Deal to Supply 3,000 Drones to Steve Wozniak via 'Woz EDU" Partnership.
Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!
Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...
OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
Another Look at the Snowflake (SNOW) Mega IPO.
We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...
First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.
The Company You Keep..
First, tiny OMNIQ announces a partnership with Zebra (ZBRA) with $4 billion in revenues. And...
Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
